<prompt> Progesterone release rate in Progestasert is:25 mgday40 mgday65 mgday80 mgday  <response>: Ans: c 65mgdayShaws Textbook 15th editionINTRAUTERINE CONTRACEPTIVE DEVICESA. Biologically inert devices: Lippes loop and Saf-T-coil.B. Copper carrying devices: Copper T 200, Copper 7, Multiload Copper 250, Copper T 380, Copper T 220 and nova T.About 50 pg of copper is eluted daily,Nova-T has silver added to the copper wire.C. Hormonal lUCDsProgestasertLevonova. 38 mg progesterone. Release 65mgday. Expensive and Effective for 1 year. 40 reduction of menorrhagia and dysmenorrhea. 60 mg of levonorgestrel. Releases the hormone in very low doses 20mgday. Incidence of ectopic pregnancy more. Safe during lacation. Longer acting 5 yearsMIRENA: Emerging as a better alternative to tubectomy in a young womanMIRENA. 52 mg Levonorgestrel. Releases 20mgday, from 15 mins following insertion. Less systemic side effects. Does not suppress ovulation, mainly acts on the endometrium and cervical mucus. Used in DUB, endometrial hyperplasia, HRT, and with tamoxifen for Ca. Breast, to counteract endometrial hyperplasia. Lasts for 5 years with fewer incidences for Ectopic gestation. Patient selection for IUCD:. Low risk of PIDSTD. Multiparous woman. Monogamous relationship. Desirous of long-term reversible method of contraception. Unhappy or unreliable users of oral contraception or barrier contraceptionUses of IUCD:. As a contraceptive. Post coital contraception emergency contraception. Following excision of uterine septum, Ashermans syndrome. Hormonal IUCD in menorrhagia and dysmenorrhea and hormonal replacement therapy in menopausal women. In a woman on tamoxifen for Ca. Breast, to counteract endometrial hyperplasiaContraindications:. Suspected pregnancy. Pelvic inflammatory disease PID, lower genital tract infection. Presence of fibroids-because of misfit. Menorrhagia and dysmenorrhea. Severe anemia. Diabetic women who are not will controlled- because of slight increase in pelvic infection. Previous ectopic pregnancy. Scarred uterus and uterine anomalies. In unmarried nulliparous because of the risk of PID and subsequent tubal infertility. Levonorgestrel IUCD in breast cancerComplications:Immediate:. Difficulty in insertion. Vaso vagal attack and Uterine cramps Early:. Expulsion 2-5. Perforation 1-2. Spotting, menorrhagia 2-10 and Dysmenorrhea 2-10. Vaginal infection Actinomycosis Late:. PID-2 to 5, occurs in the 4th week. Does not prevent transmission of HIV. Pregnancy -1 to 3 per 100 women years failure rate. Ectopic pregnancy. Perforation. Menorrhagia and dysmenorrheaInsertion technique:CuT -withdrawal methodLippes - push in methodLifespan:Cu380A Para guard : 10 yearsCu T 200 : 3-4 yearsMultiload Cu250 : 3 yearsCu375 : 5 yearsNova T 5 yearsCuT380Ag and CuT380S : 3-4 yearsRecent advances:Frameless IUCD and fibroblast releasing 14mgday for 3 years.Frameless IUCD contains several copper cylinders tied together on a string and it is anchored 1 cm deep in the fundus. 